Head H H, Delouis C, Fèvre J, Kann G, Terqui M, Djiane J
Reprod Nutr Dev (1980). 1982;22(4):641-50. doi: 10.1051/rnd:19820506.
A short-term treatment with estradiol-17 beta and progesterone induced mammary gland growth and lactogenesis in non-pregnant ewes. These events normally occur during the second half of pregnancy. In order to compare the hormonal environment during the treatment to that during pregnancy, the concentrations of total estrogens (TE), progesterone (P4), glucocorticoids (G) and prolactin (Prl) in the plasma were characterized in non-pregnant, intact ewes induced into lactation with subcutaneous injections of estradiol-17 beta (E2-beta) and P4 for 7 consecutive days (days 1 to 7). Eight non-pregnant, intact, multiparous ewes were divided into two groups (groups I and II, 4 ewes each), according to their milk yields recorded during the previous lactation. All the ewes received the short-term treatment with E2-beta and P4; the ewes of group II were also injected with hydrocortisone acetate (H) and growth hormone (GH) twice daily on days 18 to 20. Blood was collected twice daily for 21 days and milking was initiated 19 days after the first injection of E2-beta and P4. Concentrations of TE, P4, G and Prl were measured in the plasma of ewes in group I but only G and Prl were measured in the plasma of the ewes in group II. Two ewes of group I and one of group II failed to lactate. Mean milk yields (2.5 +/- 0.4 and 6.3 +/- 0.9 kg/34 days) were highest when injections of H and GH were included. Average pretreatment concentrations of plasma TE and P4 were 3.1 +/- 0.8 and 2.1 +/- 0.4 ng/ml, respectively; these increased to 10.2 +/- 1.3 and 5.6 +/- 0.6 ng/ml during the week of the E2-beta and P4 injections. Peak concentrations occurred on days 7 and 6, respectively, and the plasma levels had returned to pretreatment values by days 18 to 20. Concentrations of G in plasma were higher (13.0 +/- 1.0 ng/ml) during E2-beta and P4 injections than during pre- or post-injection (7.4 +/- 1.4 and 8.2 +/- 0.7 ng/ml, respectively). Plasma Prl showed biphasic two to six-fold increases on days 4 and 7 during E2-beta and P4 injections and thereafter declined to lower average daily concentrations on days 10 to 13. Plasma Prl began to increase, and its average concentration was 579 +/- 56 ng/ml by days 18 to 20. These results suggest that the amount of the P4 injections should be increased and that the treatment with E2-beta and P4 should last long enough to insure the induction of an endocrine balance which would correspond more accurately to the hormonal events occurring during the second half of pregnancy in the ewe.
用17β-雌二醇和孕酮进行短期治疗可诱导未孕母羊的乳腺生长和泌乳。这些过程通常发生在妊娠后半期。为了比较治疗期间与妊娠期间的激素环境,对皮下注射17β-雌二醇(E2-β)和孕酮连续7天(第1至7天)诱导泌乳的未孕、未阉割母羊血浆中的总雌激素(TE)、孕酮(P4)、糖皮质激素(G)和催乳素(Prl)浓度进行了表征。根据之前泌乳期记录的产奶量,将8只未孕、未阉割、经产母羊分为两组(I组和II组,每组4只)。所有母羊均接受E2-β和P4的短期治疗;II组母羊在第18至20天还每天注射两次醋酸氢化可的松(H)和生长激素(GH)。连续21天每天采集两次血液,在首次注射E2-β和P4后19天开始挤奶。测定了I组母羊血浆中TE、P4、G和Prl的浓度,但只测定了II组母羊血浆中的G和Prl。I组有2只母羊和II组有1只母羊未泌乳。当加入H和GH注射时,平均产奶量最高(2.5±0.4和6.3±0.9千克/34天)。血浆TE和P4的预处理平均浓度分别为3.1±0.8和2.1±0.4纳克/毫升;在注射E2-β和P4的一周内,这些浓度分别增加到10.2±1.3和5.6±0.6纳克/毫升。峰值浓度分别出现在第7天和第6天,到第18至20天血浆水平已恢复到预处理值。注射E2-β和P4期间血浆G浓度较高(13.0±1.0纳克/毫升),高于注射前或注射后(分别为7.4±1.4和8.2±0.7纳克/毫升)。注射E2-β和P4期间,血浆Prl在第4天和第7天出现两到六倍的双相增加,此后在第10至13天降至较低的日均浓度。血浆Prl开始增加,到第18至20天其平均浓度为579±56纳克/毫升。这些结果表明,应增加P4的注射量,并且E2-β和P4的治疗应持续足够长的时间,以确保诱导出一种内分泌平衡,这种平衡将更准确地对应于母羊妊娠后半期发生的激素事件。